Login / Signup

Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report.

Mohsen Khosravi
Published in: Journal of medical case reports (2020)
Ursodeoxycholic acid augmentation seems to be an effective treatment strategy for patients with treatment-refractory schizophrenia. However, further investigations in this field need to be carried out through randomized controlled trials.
Keyphrases
  • randomized controlled trial
  • bipolar disorder
  • systematic review
  • clinical trial
  • combination therapy
  • soft tissue
  • study protocol